5 Reasons That Make Cigna (CI) an Attractive Stock to Own
Zacks Investment Research | Jul 06, 2020 01:07AM ET
Cigna Corp.
Acquisition of Express Scripts (NASDAQ:ESRX): Cigna has acquired the largest pharmacy benefit manager Express Scripts holding for $67 billion, including $15 billion in debt. The merged company is now a one-stop shop for customers' healthcare needs, ranging from sale of drugs to insurance cover. It aids consumers by bringing together medical care and pharmacy benefits under one roof to improve treatments and lower costs. The combined company will be able to rise in rank in the health insurance industry, strengthening its competitive position. Cigna expects the deal to increase earnings per share from $18 to the range of $20-$21 in 2021. The combined company will generate free cash flow of at least $6 billion in 2021.
Increase in Top Line: The company’s revenues have been increasing consistently since the last several years. The same was up 15% in the first quarter of 2020 owing to the acquisition of Express Scripts. The consistent top-line growth has been driven by a number of acquisitions, the company’s superior operating performance plus provision of quality products and services. For 2020, the company expects consolidated adjusted revenues in the range of $154 million to $156 billion, indicating growth of 10% to 11%.
Impressive Bottom Line: Along with top-line growth, Cigna has been able to maintain bottom-line profitability, evident from annual earnings growth since 2009 (with the exceptional year being 2016 when earnings per share declined 6.4%). This operating profitability has been maintained by controlling medical care cost and other operating costs. In the first quarter of 2020, the company’s bottom line grew 20% year over year. For 2020, consolidated adjusted income from operations is expected to be $6.8 billion to $7 billion or $18 to $18.60 per share. This suggests growth in the range of 9% to 13% over 2019 baseline earnings. For 2021, the company targets EPS of $20 to $21.
Business Streamlining: The company has announced sale of its non-health insurance unit, Group Life and Disability insurance business to New York Life, America’s largest mutual life insurer. The sale valued at $6.3 billion is expected to fetch $5.3 billion and is likely to close in the third quarter of 2020. This move is in line with the company’s efforts to reduce its debt level, which increased after the buyout of Express Scripts for $54 billion, last year. The deal required Cigna to borrow funds. Part of the fund from the sale proceeds will be used for buying back shares. The divestiture will have no material impact on Cigna 2020 earnings but will add slightly to 2021 earnings.
High Return on Equity: The ratio, which measures the profit generated by the company for its shareholders, stands at 15.1% compared with its industry average of 8.12%. This reflects the company’s superior operating profitability.
Get The News You Want
In the past three months, the stock has gained 7.5% compared with its industry ’s growth of 19.6%.
Other stocks worth considering in the healthcare industry are Centene (NYSE:CNC) Corp. TDOC . Each of these stock carries the same Zacks Rank as Cigna.
Teladoc and Centene surpassed estimates in two of the past four reported quarters and missed in two.
Molina Healthcare beat estimates in three of the past four reported quarters and missed in one.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.